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Abstract
Background: Despite the increased attention for assessing the effectiveness of implementation strategies, most
implementation studies provide little or no information on its associated costs. The focus of the current study was
to provide a detailed report of the resource use and costs associated with implementation of a short stay
programme for breast cancer surgery in four Dutch hospitals.
Methods: The analysis was performed alongside a multi-centre implementation study. The process of identification,
measurement and valuation of the implementation activities was based on recommendations for the design,
analysis and reporting of health technology assessments. A scoring form was developed to prospectively determine
the implementation activities at professional and implementation expert level. A time horizon of 5 years was used
to calculate the implementation costs per patient.
Results: Identified activities were consisted of development and execution of the implementation strategy
during the implementation project. Total implementation costs over the four hospitals were €83.293. Mean
implementation costs, calculated for 660 patients treated over a period of 5 years, were €25 per patient. Subgroup
analyses showed that the implementation costs ranged from €3.942 to €32.000 on hospital level. From a local
hospital perspective, overall implementation costs were €21 per patient, after exclusion of the costs made by the
expert centre.
Conclusions: We provided a detailed case description of how implementation costs can be determined. Notable
differences in implementation costs between hospitals were observed.
Trial registration: ISRCTN: ISRCTN77253391
Background
Innovations often do not translate automatically into
routine care [1]. Therefore, investment in active imple-
mentation is generally needed to introduce and embed
changes in health care practice [2, 3]. Implementation is
a complex process and there are no magic bullets for
optimal implementation success [4, 5]. The value of
implementation strategies depends on both the degree
of change achieved following implementation and on the
efforts and costs associated with implementation. Imple-
mentation costs can be made during the innovation
development, implementation strategy development and
the execution of the implementation strategy [6]. Not
including costs and effects related to implementation of
an innovation may produce biased and overestimated
cost-effectiveness results [7]. Also, costs of the health
care process itself may have changed. Whereas the num-
ber of reports on effectiveness of implementation activ-
ities is increasing [8], most implementation studies do
not report implementation costs. Even if implementation
costs are reported, details as regards to the methods
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used for the identification, measurement and valuation
of the costs are mostly lacking [9–12]. Providing such
details will offer some methodological guidance, which
may lead to more robust and generalisable study find-
ings. Also, accurate information on activities and costs
associated with implementation of an innovation is
important for policymakers such as hospital managers,
especially regarding institutions where implementation
of an innovation has not yet taken place.
Between 2004 and 2007, a study was performed regarding
multi-centre implementation of a short stay programme for
breast cancer surgery (SSP) [13]. Short stay was defined as
admission, surgery and discharge the same day (day-case
admission) or discharge within 24 h after surgery (also
referred to as overnight stay). The SSP consisted of 29 rec-
ommendations and was aimed at improving patient educa-
tion, providing more standardised and better organised
care, reducing hospital stay, and high quality of care as
assessed by patients. Results of the economic evaluation
comparing SSP with care as usual revealed that the inter-
vention SSP was more cost-effective, both from a societal
and a health care point of view, mainly due to a substantial
cost reduction [14, 15].
In the current study, we provide a detailed report of the
resource use and costs associated with a hospital-tailored
strategy to implement SSP in four early adopter hospitals.
Methods
Design
In the present prospective observational study, an imple-
mentation cost-analysis was performed. This study was
executed alongside a multi-centre before-after implemen-
tation study, from December 2004 until December 2007
in the Netherlands. The protocol of the implementation
study has been published elsewhere [13].
Implementation costing method
The implementation costing method focused on the pro-
spective identification, measurement and valuation of im-
plementation activities. Revealed implementation costs
were based on the investments (e.g. time, materials) made
by the hospitals, for which they did not receive a financial
compensation. The process of identification, measurement
and valuation of the implementation activities was based
on recommendations for the design, analysis and report-
ing of health technology assessments [16, 17]. Drummond
and co-workers described these recommendations to im-
prove the reporting and the generalisability of economic
evaluations. In the current study, implementation costs
were determined from the hospitals’ perspective and from
the perspective of the external implementation team.
To facilitate prospective micro-costing in measurement
of the implementation costs, a scoring form was devel-
oped to identify and measure activities referring to
personnel costs and material costs (e.g. travel costs and
institutional incentives) dedicated to implementation
activities (Additional file 1). The scoring form had to be
filled out individually by each health care professional
participating in plenary local team meetings in each of the
hospitals and by experts of the Maastricht University
Medical Centre (MUMC). To determine the content, the
intensity and duration of the activities on an individual
level, the name and position of the person who filled out
the form, the date of activities, the time spent on the
activity, a description of the activities (e.g. the forms also
addressed time spent on writing emails to the researcher)
and the names and positions of the other attendees were
recorded. The forms were collected by the researcher dur-
ing the plenary meetings or, if a person was not able to at-
tend these, the forms were sent by mail to the researcher.
All activities scored by the attendees were checked by the
researcher and the cost-effectiveness expert to prevent
miscalculations. A time horizon that captured the ex-
pected consequences [18] of the implementation strategy
was used to determine the mean implementation costs
per patient. This time horizon was set at 5 years. Imple-
mentation costs were calculated by multiplying resource
use with a cost-price per unit of resource use. Health care
professionals’ time-related costs were calculated based on
the staff member’s gross salary per hour [19], including
38 % employers’ social charges and 10 % housing costs
(i.e. depreciation and maintenance of buildings and appar-
atus) multiplied by the number of hours. Costs were
expressed as 2013 Euros (€).
Study population and setting
The study was performed in four Dutch hospitals recog-
nised as early adopter hospitals regarding breast cancer
care. Early adopter hospitals are active in changing and in-
novating health care and function as a reference group for
most innovators [20]. The participating hospitals were a
university hospital, a large training hospital, a small train-
ing hospital and a non-training hospital.
The implementation strategy
The specific strategies will be discussed in the results,
but the generic aspects are that the implementation
strategy was targeted at the professionals involved in the
breast cancer surgery process and was externally guided
by an expert team from the MUMC. The expert team
consisted of a researcher, an implementation expert, a
cost-effectiveness expert, a statistician and the project
leader (oncologic surgeon). The strategy was hospital-
tailored as it was executed according to the model of ef-
fective implementation by Grol and Wensing to address
the specific circumstances in each of the participating
hospitals [1, 21]. The implementation strategy was devel-
oped and executed over a time period of 36 months.
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Data analyses
Implementation activities were categorised in implemen-
tation phases: development of the strategy to implement
SSP (developmental costs) and costs for execution of the
strategy (execution costs) [6]. As the innovation (i.e. the
SSP guidelines) was developed at the expert centre, one-
time costs related to the development of the innovation
before implementation were not included [18]. Research-
related costs (e.g. time spent on writing scientific papers
on the implementation study) were excluded from the
analysis. Subgroup analyses of implementation costs were
performed on hospital level and from a hospital perspec-
tive after exclusion of the costs made by the expert centre.
Results
Study population
Between December 2004 and December 2007, hospital-
tailored strategies were developed and executed in the
four participating hospitals. Surgeons, breast nurses, nurse
practitioners, department heads, department nurses, team
leaders and home care nurses were represented in most of
the executed activities. Participants who were present in
lower frequency were staff advisors, research nurses,
division managers, financial advisors, anaesthesiologists,
anaesthesiology nurses, liaison nurses, secretaries and
social workers. Table 1 displays which disciplines were
involved in each hospital.
Implementation activities
Different types of implementation activities were con-
ducted during the implementation project. A multi-faceted
implementation strategy was developed and executed in
each participating hospital, tailored to the hospital’s specific
needs and guided by the expert team. Table 2 shows the
executed activities and the duration of the activities on
hospital level. Strategy development related meetings were
organised at the expert centre. During the expert meetings
at the expert centre, important issues were discussed: steps
and decisions taken previously by the researcher, the ex-
ploration of barriers and facilitators as part of the problem
analysis for implementation and the implementation strat-
egy. Main achievements were preparation and summarisa-
tion of the implementation strategy, the latter serving as
reminders concerning agreements that had been made and
assignments regarding implementation activities for each
participant in the meeting (e.g. the breast nurse developing
flyers and the surgeon corresponding with hospital man-
agers). For the organisation and content of the meetings,
the researcher was supported by the expert team. Before
the start of the implementation strategy, educational meet-
ings were organised at each hospital to provide the local
project leaders information about SSP.
During the execution of the implementation strategy,
outreach visits were performed by a researcher with the
local team (plenary multidisciplinary team meetings) or
with the local breast nurses. In the first plenary local
team meeting, SSP was explained and discussed. Subse-
quent meetings were used to identify barriers and facili-
tators for the implementation of SSP during the project,
to tailor the implementation strategy to the needs and
wishes of each hospital, to discuss problems that had
arisen and to provide feedback on current performance;
professionals learned to what extent they adhered to the
SSP recommendations and how patients perceived qual-
ity of care. Minutes were made of each plenary local
team meeting. Clinical lectures were given by an experi-
enced breast nurse from the expert centre to the home
care nursing teams and to nurses on the ward. Teams
that achieved good performance and needed some
motivation received an incentive, for example, snacks
during a coffee break. Overall, preparation of project
meetings with experts and small-scale meetings were the
most frequently performed activities. Participants from
all hospitals accounted for a total of 450 h spent on
plenary multidisciplinary team meetings.
Implementation costs
Total implementation costs in the four hospitals were
€83.293. In Table 2, the costs of the implementation strat-
egy are presented as total costs and as costs on hospital
level. The three largest cost components of the total im-
plementation costs were plenary multidisciplinary team
Table 1 Involvement of the disciplines on hospital level during
implementation
Function Hospital 1 Hospital 2 Hospital 3 Hospital 4
Nurse practitioner No Yes No Yes
Breast care nurse Yes Yes Yes Yes
Surgeon Yes Yes Yes Yes
Radiologist No No No Yes
Team leader Yes Yes Yes Yes
Staff advisor yes Yes No No
Ward manager yes Yes No Yes
Division manager yes Yes No No
Financial advisor yes No No No
Anaesthesiologist yes Yes No No
Anaesthesiology nurse Yes Yes No No
Secretary yes Yes No No
Social worker No Yes No No
Admission planner yes No No yes
Nuclear specialist Yes No No No
Senior nurse Yes Yes Yes Yes
Junior nurse Yes Yes Yes Yes
Liaison nurse Yes Yes No Yes
Patient support member No No No Yes
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Table 2 Summary of hospital-tailored implementation strategy activities and costs to implement a short stay programme for breast cancer surgery
Total Hospital 1 Hospital 2 Hospital 3 Hospital 4 Expert centre
Type of implementation costs Costs (€) n (hours) Costs (€) n (hours) Costs (€) n (hours) Costs (€) n (hours) Costs (€) n (hours) Costs (€)
Developmental costs
Expert meeting
Expert meeting at the expert centre 1.307 N.A N.A N.A N.A N.A N.A N.A N.A 8 1.307
Educational meeting
Information provision to local project leaders 2.072 5 518 5 518 5 518 5 518 N.A N.A
Subtotal 3.379 518 518 518 518 1.307
Developmental costs/execution costs
Multidisciplinary meeting
Plenary multidisciplinary team meetings 37.699 55.1 16.580 22.1 7.010 2 1.074 28.3 7.367 105 5.669
Small meetings (average 2.9 participants) 11.520 26.9 5.463 6.4 1.161 8.3 1.842 10.5 2.707 N.A N.A
Meetings to adapt the guideline to
the local level
9.923 25.3 2.418 50.3 4.087 0 0 23.7 3.287 1 131
Communication and media
Telephone conference 578 3.0 403 1.6 175 0 0 0 0 N.A N.A
E-mail conference 290 0.7 55 3.5 235 0 0 0 0 N.A N.A
Development of instruction leaflet 255 0.5 23 4.3 231 0 0 0 0 N.A N.A
Travel costs 7.143 N.A 120 0 0 0 0 0 0 N.A 7.023
Subtotal 60.265 25.063 12.899 2.916 13.360 12.823
Execution costs
Education
Training staff at the expert centre 847 0 0 1 54 0 0 8 793 N.A N.A
Clinical lectures given by the breast nurse
from the expert centre
11.464 40 6.314 7.5 2.321 1 508 9.0 2.320 1.8 347
Incentive
Institution incentive 195 0.1 105 0 0 0 0 0.1 90 N.A N.A
Subtotal 12.507 6.419 2375 508 3.204 347
Total 83.293 32.000 15.792 3.942 17.082 14.477
Gross salary per hour (excluding social charges and housing costs): junior nurse, secretary, admission planner: €27,–; breast nurse, home care nurse, member patient support group: €30,–; anaesthetic nurse, senior
nurse, social worker: €31,–; nurse practitioner, team leader, ward manager, phD student: €35−; staff advisor: €44,–; ICT expert: €47,–; financial advisor, implementation expert, cost-effectiveness expert, statistician: €51,–;
division manager: €60,–; surgeon, anesthesiologist, radiologist, nuclear specialist: €69,–; project leader: €79,–. Costs are expressed in 2013 Euros
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meetings, small meetings (on average consisting of less
than three persons) and clinical lectures. Figure 1 shows
the cumulative implementation costs of the hospital-
tailored strategy over time. Costs in 2007 were mainly re-
lated to plenary multidisciplinary team meetings and mak-
ing the minutes of these meetings. Table 2 shows that 660
patients are treated in the four participating hospitals
yearly. Using a time horizon of 5 years, 3.300 (5 × 660) pa-
tients are treated in the four early adopter hospitals. Mean
implementation costs assessed for 660 patients treated per
year with a time horizon of 5 years were €25 (€83.293/
3.300) per patient.
Subgroup analyses
As the implementation strategy was tailored to local
needs, differences in the type and in the intensity of im-
plementation activities were shown on hospital level.
Hospital 1 showed the highest level of development and
execution activities, and in hospital 3, the smallest num-
ber of activities was needed to implement SSP. Hospitals
2 showed a relatively high level of communication by e-
mail, whereas for hospital 1 and 3, more small-scale
face-to-face meetings were executed. On hospital level,
the implementation costs ranged from €3.942 in hospital
3 to €32.000 in hospital 1. From a local hospital perspec-
tive, implementation costs were €21 per patient in a time
horizon of 5 years (€68.816/3.300), after exclusion of the
costs made by the expert centre (€83.293 − €14.477).
Discussion
In the current study, we determined the resource use
and costs associated with the implementation of SSP in
four early adopter hospitals, using a structured method-
ology for identification, measurement and valuation of
activities. The innovation was implemented by means of
a hospital-tailored strategy which was externally guided
by an expert team. Most costs were caused by project
meetings with implementation experts, clinical lectures
and small-scale meetings. This study showed that the
overall mean implementation costs were €83.293. Imple-
mentation costs were €25 per patient when treating 660
patients a year and using a time horizon of 5 years post-
implementation.
Activities related to a change in health care provision
were not included in the current study as this part of
costs was related to the health care innovation itself and
was not part of the implementation strategy. These costs
were included in an economic evaluation of SSP versus
usual care [15]. The calculated costs in this paper reflect
the efforts and time investments by the hospitals and the
expert team, for which they were not compensated, and
therefore represent true opportunity costs.
Implementation is a complex process and there is no
standard strategy for reaching optimal implementation
success against the lowest possible costs. As a conse-
quence, implementation costs may vary per implementa-
tion project and on institutional level. The study shows
Fig. 1 Overall cumulative implementation costs over time
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that implementation costs varied widely between hospi-
tals, which can be expected given the fact that the imple-
mentation strategy was tailored to the hospitals’ needs
and circumstances. Notably, an association seemed to be
present between the uptake of short stay and total im-
plementation costs per hospital. After finishing the
hospital-tailored implementation strategies, in hospital 3,
the uptake of the proportion of patients treated in short
stay after breast cancer surgery somewhat decreased
(−7 %) compared to the preimplementation measure-
ment [15] and implementation costs were €3.942. In
hospital 2, the uptake was 37 % and implementation
costs were €15.792, in hospital 4 the uptake was 52 %
and implementation costs were €17.082, and in hospital
1, the uptake was 71 % and implementation costs were
€32.000. It is unknown whether or not the proportions
of patients treated in short stay would have been higher
if other or more implementation activities had been per-
formed. In hospital 1, health care professionals showed
more need of guidance by the expert team than the
other hospitals. Although the implementation costs in
hospital 1 were twice as high compared with hospital 2,
the uptake of short stay was also almost twice as high.
Implementation uptake and costs in hospital 3 showed
to be lower compared to other hospitals as this hospital
started a self-initiated implementation before the start of
the official project [15]. The current study provided
detailed insight in total implementation costs, as well as
implementation costs per hospital and per patient. How-
ever, due to an increased breast cancer incidence rate
[22], more patients may have been treated in the four
hospitals. Treating more breast cancer patients affects the
implementation costs on patient level. Therefore, imple-
mentation costs on patient level may be overestimated.
We believe that the implementation activities collected
by the health care professionals were a true representa-
tion of reality, as many activities had been attended by
different health care professionals and there was a high
agreement in scoring of activities between health care
professionals. A weakness of the current study may be
that the period of measurement of implementation activ-
ities was restricted to the duration of the implementa-
tion project. It is likely that more activities have been
performed before or after the formal implementation
project. For example, the study was performed in four
hospitals recognised as early adopter and between ap-
proval for study participation and actual start of the
study; some professionals from hospital 3 had already
visited the expert centre to learn about SSP. The early
adopter status was strengthened by the observation that
the uptake of short stay seemed to have started already
during the care as usual period in one hospital, i.e. be-
fore the beginning of externally guided implementation
project [15]. As the implementation project was not
formally started at that time, the implementation activ-
ities associated with this early adoption were not mea-
sured prospectively and were therefore not included in
the current study. Consequently, it can be argued that
the implementation costs are underestimated. To iden-
tify and measure all implementation costs, it could be
recommended in future research to keep a structured
implementation cost log book on hospital level to track
implementation activities prospectively before, during
and after the formal implementation project. As the ac-
tivities were not specified on the scoring form, activities
may have been missed as they were not perceived as im-
plementation related. On the other hand, costs may be
overestimated in case an activity was also performed for
other purposes than implementation. It is therefore also
recommended in future research to develop a (digital)
implementation log book with prespecified implementa-
tion activities to be scored on a weekly basis. This form
needs to be tested as part of a pilot.
Recent developments
The current study presented a detailed description of the
identification, measurement and valuation of costs by
using methodological guidance [10], which enables com-
parability and reproducibility of the executed strategy by
providing detailed and structured information [11].
Recently, the Effective Practice and Organisation of Care
(EPOC) Data Collection Checklist intervention categories,
the behaviour change wheel, Leeman taxonomy and be-
haviour change techniques were mapped together in order
to develop a more uniform taxonomy and to generate a
common implementation activity terminology [23]. This
new construction is in its infancy and is a starting point
for a new framework aimed at mapping implementation
activities. Also, Powell and colleagues [24] recently pub-
lished a refined compilation of implementation strategies
to improve conceptual clarity. These conceptualisations of
implementation activities can be used in future research
to determine implementation costs. Moreover, the find-
ings of this study suggest that in case of a hospital-tailored
implementation strategy, implementation costs need to be
determined at an institutional level.
Conclusions
This study involved a cost-analysis performed using gener-
ally accepted principles on implementation of innovations
and cost calculations. We provided a case description of
how implementation costs can be determined prospect-
ively using a structured and transparent approach to iden-
tification, measurement and valuation. The current study
may offer methodological guidance to future implementa-
tion cost studies which may facilitate the generalisability
of implementation study findings.
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Additional file
Additional file 1: Implementation activities scoring form. This file
contains the implementation activity scoring form that was developed
and used in the current study.
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